期刊论文详细信息
Frontiers in Oncology
Corrigendum: Anlotinib Combined With Anti-PD-1 Antibodies Therapy in Patients With Advanced Refractory Solid Tumors: A Single-Center, Observational, Prospective Study
关键词: anlotinib;    anti-PD-1 antibody;    angiogenesis;    immunotherapy;    serum cytokine;   
DOI  :  10.3389/fonc.2021.796625
来源: DOAJ
【 授权许可】

Unknown   

  文献评价指标  
  下载次数:0次 浏览次数:0次